PAR · EL.PA
EssilorLuxottica S.A.
€178.20+€0.50 (+0.28%)
EssilorLuxottica S.A.’s quoted price sits in the lower half of its reported 52-week range, 44.97% below the high.
Loading market information…
NSE · LENSKART.NS · INR
Stock price, earnings
Quote as of Oct 29, 2026, 10:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Lenskart Solutions Limited’s quoted price sits in the upper half of its reported 52-week range, 5.97% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Lenskart Solutions Limited’s next earnings report is currently expected on Dec 2, 2026, with estimated earnings per share of ₹1.19. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Lenskart Solutions Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Lenskart Solutions Limited, a technology-driven eyewear company, engages in designing, manufacturing, branding, and retailing of eyewear products in India, Japan, Southeast Asia, and the Middle East. The company's products include prescription eyeglasses, sunglasses, goggles, screen glasses, and other products, such as contact lenses and eyewear accessories, including frames for men, women, and kids. It engages in lens manufacturing, lens edging, lens design, frame design, frame manufacturing, and delivery. The company operates as a direct-to-consumer company that designs and sells a wide range of eyewear products under the Lenskart and Owndays brands; and sub brands, including John Jacobs, Vincent Chase, Hooper, Lenskart Air, and Hustlr. It sells its products through online and offline channels, such as retail stores, websites, mobile applications, and other channels. The company also owns and operates eyewear retail stores in India and provides home eye check-up services. Lenskart Solutions Limited was incorporated in 2008 and is based in Gurugram, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
€178.20+€0.50 (+0.28%)
EssilorLuxottica S.A.’s quoted price sits in the lower half of its reported 52-week range, 44.97% below the high.
¥26,150-¥180 (-0.68%)
HOYA Corporation’s quoted price sits in the lower half of its reported 52-week range, 13.98% below the high.
₹1,761.00+₹3.50 (+0.2%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.97% below the high.
CHF 58.76+CHF 1.12 (+1.94%)
Alcon Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.02% below the high.
₹9,664.00+₹105.50 (+1.1%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.78% below the high.
₹4,580.00+₹23.00 (+0.5%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 12.76% below the high.
₹2,244.00+₹62.10 (+2.85%)
Laurus Labs Limited’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
CA$28.75+CA$0.19 (+0.67%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.3% below the high.
